A bidirectional approach for percutaneous coronary intervention for chronic total occlusion (CTO-PCI) using ipsilateral collaterals with a single guiding catheter limits procedural choices. The CTO of the left circumflex artery with ipsilateral collateral artery was treated by the bidirectional approach using a single guiding catheter. While the retrograde wire directly crossed the CTO lesion, the microcatheter could not pass the CTO lesion despite the conventional strategies. Therefore, we performed the wire rendezvous and chasing wire techniques. The wire rendezvous technique enables deeper retrograde guidewire progression, and the antegrade microcatheter can reach the CTO entry. The chasing wire technique enables the antegrade guidewire to pass the route made by the retrograde guidewire. These techniques might offer a possible solution for bidirectional CTO-PCI using a single guiding catheter. However, this technique should be considered as a last resort because of the risk of rapid reocclusion.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232790 | PMC |
http://dx.doi.org/10.1155/2018/7162949 | DOI Listing |
J Integr Neurosci
December 2024
Department of Computer Science and Engineering, Shaoxing University, 312000 Shaoxing, Zhejiang, China.
Background: Motor imagery (MI) plays an important role in brain-computer interfaces, especially in evoking event-related desynchronization and synchronization (ERD/S) rhythms in electroencephalogram (EEG) signals. However, the procedure for performing a MI task for a single subject is subjective, making it difficult to determine the actual situation of an individual's MI task and resulting in significant individual EEG response variations during motion cognitive decoding.
Methods: To explore this issue, we designed three visual stimuli (arrow, human, and robot), each of which was used to present three MI tasks (left arm, right arm, and feet), and evaluated differences in brain response in terms of ERD/S rhythms.
Front Immunol
December 2024
Myeloid Therapeutics, Inc., Cambridge, MA, United States.
Introduction: The approval of chimeric antigen receptor (CAR) T cell therapies for the treatment of B cell malignancies has fueled the development of numerous cell therapies. However, these cell therapies are complex and costly, and unlike in hematological malignancies, outcomes with most T cell therapies in solid tumors have been disappointing. Here, we present a novel approach to directly program myeloid cells by administering novel TROP2 CAR mRNA encapsulated in lipid nanoparticles (LNPs).
View Article and Find Full Text PDFCureus
November 2024
Education, Twin Oaks Anesthesia Services, Wesley Chapel, USA.
Open or arthroscopic repair of hamstring tear requires both hard and soft, posterior and proximal thigh analgesia. Regional injections to completely relieve this unique pain are not available to the best of our knowledge. We present a novel, single injection, performed under ultrasound guidance, that utilizes the deep piriformis space.
View Article and Find Full Text PDFCureus
November 2024
Ophthalmology, District General Hospital Trincomalee, Trincomalee, LKA.
Introduction The Sri Lankan economic crisis that began in 2019 led to the suspension of cataract services in many districts. Although humanitarian missions were quick to supply materials, there was a lack of scientific evidence to predict the required intraocular lens power for patients with cataracts. This study aimed to assess the average lens power among patients from Trincomalee district, Sri Lanka, based on sex and age groups.
View Article and Find Full Text PDFJ Nanobiotechnology
December 2024
Department of Urology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Castration-resistant prostate cancer (CRPC) presents significant therapeutic challenges due to its aggressive nature and poor prognosis. Targeting Aurora-A kinase (AURKA) has shown promise in cancer treatment. This study investigates the efficacy of ART-T cell membrane-encapsulated AMS@AD (CM-AMS@AD) nanoparticles (NPs) in a photothermal-chemotherapy-immunotherapy combination for CRPC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!